Go to deals
Healthcare | TMT

Renita Medical raises seed funding

Renita Medical Oy, a healthtech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.

Renita Medical is building a personalized brain health solution. The company’s AI-based software, the RENITA platform, uses a patient’s own functional brain activity and combines it with proven cognitive assessment tools to provide a comprehensive and objective report, from which doctors can base their neurological diagnosis. The platform will enhance the neurological diagnosis process and will offer an efficient way to monitor brain health.

Oaklins’ team in Finland acted as the financial advisor in this transaction.

Talk to the deal team

Marcus Blomqvist

Senior Advisor
Helsinki, Finland
Oaklins Finland

Related deals

Skynamo has been acquired by Klipboard
TMT

Skynamo has been acquired by Klipboard

Klipboard, a global provider of vertical business management software, has completed the acquisition of Skynamo, a market-leading mobile field sales platform used by manufacturers, wholesalers and distributors worldwide. The acquisition adds Skynamo’s award-winning field sales platform to Klipboard’s portfolio and enhances its ability to support wholesalers, distributors and retailers in managing complex operations across many industries.

Learn more
Ebidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment
Private Equity | Industrial Machinery & Components

Ebidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment

Ebidco S.r.l. has completed a voluntary public tender offer for the shares of Eles Semiconductor Equipment S.p.A.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more